{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:31:04Z","timestamp":1791325864347,"version":"4.3.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20149-7","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:26:00Z","timestamp":1783535160000},"page":"9743-9749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nodal Pathologic Response After Neoadjuvant Systemic Therapy in Clinically Advanced Node-Positive (cN2 and cN3) Breast Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Diana M.","family":"Jaen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin E.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Helseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige A.","family":"Harwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Santamaria-Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle-Cheri","family":"Millen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"5","key":"20149_CR1","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1245\/s10434-025-16973-y","volume":"32","author":"JC Boughey","year":"2025","unstructured":"Boughey JC, Yu H, Switalla K, et al. Oncologic outcomes with de-escalation of axillary surgery after neoadjuvant chemotherapy for breast cancer: results from > 1500 patients on the I-SPY2 clinical trial. Ann Surg Oncol. 2025;32(5):3278\u201391. https:\/\/doi.org\/10.1245\/s10434-025-16973-y.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"20149_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","volume":"158","author":"S Kuemmel","year":"2023","unstructured":"Kuemmel S, Heil J, Bruzas S, et al. Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer. JAMA Surg. 2023;158(8):807. https:\/\/doi.org\/10.1001\/jamasurg.2023.1772.","journal-title":"JAMA Surg."},{"issue":"10","key":"20149_CR3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA. 2017;318(10):918. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA."},{"key":"20149_CR4","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Accessed April 12, 2026. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"issue":"1","key":"20149_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/XCS.0000000000000872","volume":"238","author":"SX Sun","year":"2024","unstructured":"Sun SX, Piotrowski MJ, Adesoye T, et al. Long-term outcomes and predictors of response in breast cancer patients with advanced nodal involvement. J Am Coll Surg. 2024;238(1):1\u20139. https:\/\/doi.org\/10.1097\/XCS.0000000000000872.","journal-title":"J Am Coll Surg."},{"issue":"13","key":"20149_CR6","doi-asserted-by":"publisher","first-page":"9767","DOI":"10.1245\/s10434-025-17906-5","volume":"32","author":"SJ An","year":"2025","unstructured":"An SJ, Thai CHNC, Agala CB, Abdou YG, Selfridge JM, Spanheimer PM. Predictors of nodal pathologic complete response after neoadjuvant chemotherapy in breast cancer. Ann Surg Oncol. 2025;32(13):9767\u201375. https:\/\/doi.org\/10.1245\/s10434-025-17906-5.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"20149_CR7","doi-asserted-by":"publisher","first-page":"8636","DOI":"10.1245\/s10434-021-10195-8","volume":"28","author":"SP Myers","year":"2021","unstructured":"Myers SP, Ahrendt GM, Lee JS, et al. Association of tumor molecular subtype and stage with breast and axillary pathologic complete response after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2021;28(13):8636\u201342. https:\/\/doi.org\/10.1245\/s10434-021-10195-8.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"20149_CR8","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1245\/s10434-021-09897-w","volume":"28","author":"A Weiss","year":"2021","unstructured":"Weiss A, Campbell J, Ballman KV, et al. Factors associated with nodal pathologic complete response among breast cancer patients treated with neoadjuvant chemotherapy: results of CALGB 40601 (HER2+) and 40603 (triple-negative) (alliance). Ann Surg Oncol. 2021;28(11):5960\u201371. https:\/\/doi.org\/10.1245\/s10434-021-09897-w.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"20149_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41523-025-00862-4","volume":"11","author":"JH Oh","year":"2025","unstructured":"Oh JH, Ahn S, Jang M, et al. Nomogram for predicting axillary pathologic complete response in cN2\u20133 breast cancer after neoadjuvant chemotherapy. NPJ Breast Cancer. 2025;11(1):149. https:\/\/doi.org\/10.1038\/s41523-025-00862-4.","journal-title":"NPJ Breast Cancer."},{"issue":"6","key":"20149_CR10","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1016\/j.clbc.2024.03.005","volume":"24","author":"JX Huang","year":"2024","unstructured":"Huang JX, Chen YJ, Wang XY, et al. Nomogram based on US and clinicopathologic characteristics: axillary nodal evaluation following neoadjuvant chemotherapy in patients with node-positive breast cancer. Clin Breast Cancer. 2024;24(6):e452-e463.e4. https:\/\/doi.org\/10.1016\/j.clbc.2024.03.005.","journal-title":"Clin Breast Cancer."},{"issue":"3","key":"20149_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10549-019-05500-9","volume":"179","author":"LH Rosenberger","year":"2020","unstructured":"Rosenberger LH, Ren Y, Thomas SM, et al. Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? Breast Cancer Res Treat. 2020;179(3):661\u201370. https:\/\/doi.org\/10.1007\/s10549-019-05500-9.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"20149_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2025.15112","volume":"30","author":"J Kang","year":"2025","unstructured":"Kang J, Xiong H, Jiang X, et al. Factors influencing pathological complete response to neoadjuvant chemotherapy in resectable breast cancer: a retrospective study. Oncol Lett. 2025;30(1):1\u201310. https:\/\/doi.org\/10.3892\/ol.2025.15112.","journal-title":"Oncol Lett."},{"issue":"6","key":"20149_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.0891","volume":"156","author":"S Samiei","year":"2021","unstructured":"Samiei S, Simons JM, Engelen SME, et al. Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis. JAMA Surg. 2021;156(6):e210891. https:\/\/doi.org\/10.1001\/jamasurg.2021.0891.","journal-title":"JAMA Surg."},{"issue":"12","key":"20149_CR14","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","volume":"26","author":"LM Spring","year":"2020","unstructured":"Spring LM, Fell G, Arfe A, et al. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res. 2020;26(12):2838\u201348. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3492.","journal-title":"Clin Cancer Res."},{"issue":"8","key":"20149_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/nejmoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567\u201375. https:\/\/doi.org\/10.1056\/nejmoa020128.","journal-title":"N Engl J Med."},{"issue":"1","key":"20149_CR16","doi-asserted-by":"publisher","first-page":"11128","DOI":"10.1038\/s41598-024-84841-y","volume":"15","author":"EJ Kim","year":"2025","unstructured":"Kim EJ, Yoo TK, Kim J, et al. Feasibility of de-escalating axillary surgery in patients with clinical N2\u20133, pathological N0 breast cancer after neoadjuvant chemotherapy. Sci Rep. 2025;15(1):11128. https:\/\/doi.org\/10.1038\/s41598-024-84841-y.","journal-title":"Sci Rep."},{"issue":"1","key":"20149_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1470-2045(25)00598-4","volume":"27","author":"G Montagna","year":"2026","unstructured":"Montagna G, Alvarado M, Myers S, et al. Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07\/microNAC): an international, retrospective cohort study. Lancet Oncol. 2026;27(1):57\u201367. https:\/\/doi.org\/10.1016\/S1470-2045(25)00598-4.","journal-title":"Lancet Oncol."},{"issue":"4","key":"20149_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","volume":"3","author":"M Pilewskie","year":"2017","unstructured":"Pilewskie M, Morrow M. Axillary nodal management following neoadjuvant chemotherapy: a review. JAMA Oncol. 2017;3(4):549. https:\/\/doi.org\/10.1001\/jamaoncol.2016.4163.","journal-title":"JAMA Oncol."},{"key":"20149_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.breast.2023.03.005","volume":"69","author":"M Heidinger","year":"2023","unstructured":"Heidinger M, Knauer M, Tausch C, Weber WP. Tailored axillary surgery\u2014a novel concept for clinically node positive breast cancer. Breast. 2023;69:281\u20139. https:\/\/doi.org\/10.1016\/j.breast.2023.03.005.","journal-title":"Breast."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20149-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20149-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20149-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:50:32Z","timestamp":1790916632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20149-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20149"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20149-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}